Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease

Proc Natl Acad Sci U S A. 2021 May 11;118(19):e2020293118. doi: 10.1073/pnas.2020293118.

Abstract

Transcriptional dysregulation in Huntington's disease (HD) causes functional deficits in striatal neurons. Here, we performed Patch-sequencing (Patch-seq) in an in vitro HD model to investigate the effects of mutant Huntingtin (Htt) on synaptic transmission and gene transcription in single striatal neurons. We found that expression of mutant Htt decreased the synaptic output of striatal neurons in a cell autonomous fashion and identified a number of genes whose dysregulation was correlated with physiological deficiencies in mutant Htt neurons. In support of a pivotal role for epigenetic mechanisms in HD pathophysiology, we found that inhibiting histone deacetylase 1/3 activities rectified several functional and morphological deficits and alleviated the aberrant transcriptional profiles in mutant Htt neurons. With this study, we demonstrate that Patch-seq technology can be applied both to better understand molecular mechanisms underlying a complex neurological disease at the single-cell level and to provide a platform for screening for therapeutics for the disease.

Keywords: Huntington’s disease; Patch-seq; single-cell RNA sequencing; striatum; synaptic function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzamides
  • Corpus Striatum / physiology
  • Disease Models, Animal
  • GABA Agents / pharmacology*
  • Gene Expression
  • Huntingtin Protein
  • Huntington Disease / genetics*
  • Huntington Disease / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Neurons / metabolism*
  • Sequence Analysis, RNA
  • Synaptic Transmission / drug effects*
  • Synaptic Transmission / genetics
  • Synaptic Transmission / physiology*
  • Transcriptome

Substances

  • Benzamides
  • GABA Agents
  • HTT protein, human
  • Huntingtin Protein
  • N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide